HM Hospitals partners with Myocardial Solutions to assess the cardiotoxicity of chemotherapy and the cardiac function of cancer patients

HM Hospitales

08/01/2024

HM Hospitals partners with Myocardial Solutions to assess the cardiotoxicity of chemotherapy and the cardiac function of cancer patients

More Posts

New advance in cardiac care in Malaga: Vithas and AEEC join forces to detect diseases with MyoStrain

Vithas signs the first Corporate License Agreement in Spain with Myocardial Solutions to implement MyoStrain® and MyoStress®

MyoStrain and MyoStress launch at Buff Medical Resort to improve cardiac care in Germany